This fall has been an exciting time for our European Academic Compound Library. We have received new submissions from several chemists worldwide, all eager to uncover new bioactivities in their…
Our colleagues at the Institute of Molecular Genetics (IMG) in Prague, CZ, and the EU-OPENSCREEN central office in Berlin, DE, have a new publication out explaining the rationale, design and curation…
We congratulate our partners at Fraunhofer ITMP on their latest publication in ACS Pharmacology & Translational Science: "Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New…
EU-OPENSCREEN's partner site Fraunhofer ITMP has created a knowledge graph generator (KGG) leveraged on the BY-COVID project and is ready to share their toolkit with you.
We recently participated in the 48th FEBS Congress in Milan, Italy, alongside our partner Life -Science Research Infrastructures Instruct-ERIC, Euro-BioImaging, and INFRAFRONTIER.In, In a special…
EU-OPENSCREEN has secured funding from the European Union for the IMPULSE project (Grant Agreement No. 101132028), short for IMProving User experience, Long-term sustainability, and Services of…
The EU-funded project Fragment-Screen [1] aims to develop innovative instrumentation, workflows, and methodologies for fragment-based drug discovery (FBDD). In a joint effort by four ESFRI Landmark…
EU-OPENSCREEN is pleased to announce that Philip Gribbon has been appointed as its Director General and wishes him well in his new role. Philip is known to many in our community for his time as…
Use our EU-OPENSCREEN services to advance your cancer research within the recently published canSERV open call for transnational service provision which is now open for applications
The paper from our colleagues at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) reports the structural evaluation and molecular determinants for selective PI3K-C2α inhibition by a…
